Harlan Waksal - Dec 9, 2024 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Signature
/s/ Jason Cavalier, Attorney-in-Fact for Harlan Waksal
Stock symbol
LYRA
Transactions as of
Dec 9, 2024
Transactions value $
$0
Form type
4
Date filed
12/11/2024, 06:39 PM
Previous filing
Jun 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYRA Performance-based Restricted Stock Units Award $0 -128K -100% $0.00 0 Dec 9, 2024 Common Stock 128K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Performance-based Restricted Stock unit ("PSU") represented a contingent right to receive one share of the Issuer's common stock.
F2 On March 21, 2024, the Reporting Person was granted a PSU for an aggregate of up to 385,000 shares of common stock under the Issuer's 2020 Incentive Award Plan (the "Agreement"). Under the terms of the Agreement, the underlying PSUs will become earned upon certain milestone events. On December 9, 2024, the Issuer determined that Milestone 1 of the PSU was achieved, resulting in 128,333 PSUs being earned. The earned PSUs will vest on January 31, 2028. The PSUs have no expiration date.